ECL Plex(TM) G-A-M IgG, Cy(R)5

General description

ECL Plex^™ Cy2-, Cy3-, and Cy5-conjugated Antibodies are part of an optimized system for quantitative analysis using fluorescent Western blotting.

Application

ECL Plex Western Blotting System is optimized for single Protein detection as well as multiplex Protein detection using ECL Plex CyDye-Conjugated Secondary Antibodies and Hybond-LFP (low-fluorescent PVDF membrane) or Hybond ECL (nitrocellulose membrane). The optimized antibodies show high sensitivity, a very good dynamic range and Low or no cross-reactivity. CyDye technology is dependable, reliable, and ensures accurate quantitation. The system is optimized on the Typhoon 9410 Scanner but is compatible with many fluorescent laser scanners and CCD cameras.
Products listed beLow are optimized for use with ECL Plex Western Blotting System:

• ECL Plex CyDye-conjugated antibodies: A43009, PA43010, PA45009, PA45010, PA45011, PA45012
• Hybond ECL: RPN2020D, RPN78D, RPN203D, and RPN3032D
• Hybond-LFP: RPN2020LFP, RPN2020LFP3, RPN1416LFP, and RPN303LFP
• ECL Plex fluorescent Rainbow markers: RPN850 and RPN85
• Blocking buffer: RPN412
• ECL Plex combination packs: RPN998 and RPN999

Features and Benefits

• ECL Plex^™ Cy2-, Cy3-, and Cy5-conjugated Antibodies are part of an optimized system for quantitative analysis using fluorescent western blotting.
• CyDye^™ fluorescent technology enables multiwavelength detection.
• Regular (600 μg) and starter (150 μg) packs are available.

Analysis Note

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Legal Information

CyDye:
Cy3B: This product is manufactured under an exclusive license from Carnegie Mellon University and is covered by US patent number 6,133,445 and equivalent patents and patent applications in other countries.
CyQ (or Cy5Q or Cy7Q): These products are covered under US patent number 6,828,116 and equivalent patents and patent applications in other countries in the name of Cytiva.
CytoCy5S: The use of this product in an NTR gene reporter assay is the subject of US patent number 7,579,140 in the name of Cytiva.
CypHer5E: This product or portions thereof is manufactured under license from Carnegie Mellon University and is covered by US patent number 7,615,646.
Cy and CyDye, are - trademarks of Cytiva or one of its subsidiaries.
The purchase of CyDye products includes a limited license to use the CyDye products for internal research and development but not for any commercial purposes. A license to use the Cy and CyDye trademarks for commercial purposes is subject to a separate license agreement with Cytiva. Commercial use shall include:
1. Sale, lease, license or other transfer of the material or any material derived or produced from it.
2. Sale, lease, license or other grant of rights to use this material or any material derived or produced from it.
3. Use of this material to perform services for a fee for third parties, including contract research and drug screening.
If you require a commercial license to use the Cy and CyDye trademarks please contact [email protected].

If you require a commercial license to use this material and do not have one, return this material unopened to Cytiva Bio-Sciences AB, Bjorkgatan 30, SE-751 84 Uppsala, Sweden and any money paid for the material will be refunded.

Cy is a registered trademark of Cytiva

CyDye is a trademark of Cytiva

ECL Plex is a trademark of Cytiva